First Pharma Fund

Overview

First Pharma Fund is a private equity fund regulated by the Portuguese Securities Market Commission (CMVM), focusing exclusively on Portugal's pharmacy sector. The fund offers investment opportunities eligible for the Golden Visa program, requiring a minimum investment of €500,000. Its primary objective is to acquire, restructure, and sell pharmacies, targeting operational improvements and sales growth to enhance profitability. The fund's strategy involves purchasing licensed pharmacies, implementing professional management practices, and optimizing operations to increase their market value. By focusing on the healthcare sector, particularly pharmacies, First Pharma Fund aims to provide investors with a stable and resilient investment opportunity. The fund is managed by experts in healthcare and Golden Visa compliance, ensuring alignment with the latest legislation and offering transparent reporting and investor support. Investors in First Pharma Fund gain access to the Portuguese Golden Visa program, which grants residency rights in Portugal and the European Union. The fund's duration is eight years, during which it seeks to deliver capital gains through strategic investments in the pharmacy sector. The fund's management team is committed to delivering exceptional results for investors, leveraging their extensive experience in pharmacy management and consultancy to navigate the complexities of the healthcare market effectively.

Investment Focus

• Eligibility for the Golden Visa program